We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.AuthorsBleumer I; Knuth A; Oosterwijk E; Hofmann R; Varga Z; Lamers C; Kruit W; Melchior S; Mala C; Ullrich S; De Mulder P; Mulders PF; Beck JPublicationBritish journal of cancer, 2004, Vol 90, Issue 5, p985ISSN0007-0920Publication typearticleDOI10.1038/sj.bjc.6601617